Keith B. Armitage
Case Western Reserve University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Keith B. Armitage.
Gerontology | 1993
Elizabeth A. Rich; Maria A. Mincek; Keith B. Armitage; Evelyn Duffy; Donna C. Owen; John D. Fayen; David L. Hom; Jerrold J. Ellner
The waning of cell-mediated immunity during aging has been attributed primarily to defects in T lymphocyte properties and functions. We assessed the potential contribution of accessory dysfunction of monocytes from the elderly on responses of T cells to phytohemagglutinin (PHA) and to tetanus toxoid after in vivo boosting. Accessory function of monocytes from the elderly subjects for T lymphocyte responses to tetanus toxoid was comparable to the young. Expression of the cytokines interleukin-1, interleukin-6 and tumor necrosis factor, the cell adhesion molecules ICAM-1 and LFA-3 and the class II major histocompatibility molecule HLA-DR by monocytes from the elderly and young subjects was similar. T lymphocytes from the elderly responded poorly to PHA. Monocytes from the elderly had a decreased accessory function for PHA-stimulated T cells from young, third donors. Thus, although many accessory properties of monocytes from the elderly are normal, the monocyte and T lymphocyte defects in the elderly for mitogen may represent interactive factors in cell-mediated immunity during aging.
Infectious Diseases in Clinical Practice | 2002
Laura Nadeau; Robert A. Salata; Michelle V. Lisgaris; Mort Goldman; Ronald Cowan; Keith B. Armitage
We evaluated whether hospitals with routine fluoroquinolone (FQ) use for community-acquired infections have higher levels of gram-negative rod (GNR) resistance to FQs than hospitals that restrict their use. We obtained antibiogram data from six community hospitals (CHs) and tertiary care hospitals (THs), and calculated resistance rates among Klebsiella pneumoniae, Serratia marcescens, Escherichia coli, and Pseudomonas aeruginosa over time. We used pharmacy purchasing data to quantitate FQ use and compared resistance rates to use. Percentages of antibiotic costs related to FQs were lower at the THs (7.5%–12.5%) than at the CHs (21%–26%). There was a significant declining trend in the sensitivity of Pseudomonas to FQs at all THs and at CH 1 and CH 3 (p = .003–.039), despite less FQ use at the THs. E. coli isolates remained highly sensitive, and there were no significant trends for S. marcescens or K. pneumoniae. Without more judicious use of FQs in the outpatient setting, restrictions at individual hospitals may not slow resistance to FQs.
JAMA Internal Medicine | 1992
Keith B. Armitage; Timothy P. Flanigan; John T. Carey; Ian Frank; Rob Roy MacGregor; Paul Ross; Richard Goodgame; John Turner
The Journals of Gerontology | 1993
Keith B. Armitage; Evelyn Duffy; Maria A. Mincek; Charlotte B. Miller; Fritz van der Kuyp; David L. Horn; Julia A. Munger; Kay Edmonds; Lavenia S. Ferguson; Elizabeth A. Rich; Jerrold J. Ellner
American Journal of Tropical Medicine and Hygiene | 2005
David B. Blossom; Charles H. King; Keith B. Armitage
Infectious Diseases in Clinical Practice | 2005
David B. Blossom; Manish D. Shah; Keith B. Armitage
The American Journal of Medicine | 2010
Fadi Seif; Keith B. Armitage; Mariana Petrozzi
The American Journal of Medicine | 1991
Keith B. Armitage; Ronald E. Blanton
Infectious Diseases in Clinical Practice | 2006
Samuel Unzek; Robert A. Salata; Keith B. Armitage
Infectious Diseases in Clinical Practice | 1993
Keith B. Armitage; Robert A. Salata; C. Seth Landefeld